Huntsworth plc (HNT) is a leading conglomerates business based in the UK. Huntsworth is listed on the London Stock Exchange (LSE) and employs 1,991 staff. All prices are listed in British Pound.
|52-week range||£2500 - £2500|
|50-day moving average||£107.5|
|200-day moving average||£88.1851|
|Wall St. target price||£148.33|
|Dividend yield||£0.03 (2.42%)|
|Earnings per share (TTM)||£5.4|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing Huntsworth stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Huntsworth's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Huntsworth's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 20x. In other words, Huntsworth shares trade at around 20x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71).
Huntsworth's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £47.9 million.
The EBITDA is a measure of a Huntsworth's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||£264.9 million|
|Operating margin TTM||14.23%|
|Gross profit TTM||£108.3 million|
|Return on assets TTM||5.13%|
|Return on equity TTM||10.98%|
|Market capitalisation||£412.7 million|
TTM: trailing 12 months
Dividend payout ratio: 43.52% of net profits
Recently Huntsworth has paid out, on average, around 43.52% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.42% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Huntsworth shareholders could enjoy a 2.42% return on their shares, in the form of dividend payments. In Huntsworth's case, that would currently equate to about £0.03 per share.
While Huntsworth's payout ratio might seem fairly standard, it's worth remembering that Huntsworth may be investing much of the rest of its net profits in future growth.
The latest dividend was paid out to all shareholders who bought their shares by 28 May 2020 (the "ex-dividend date").
Huntsworth's shares were split on a 1:5 basis on 14 July 2005. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Huntsworth shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Huntsworth shares which in turn could have impacted Huntsworth's share price.
Over the last 12 months, Huntsworth's shares have ranged in value from as little as £2500 up to £2500. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Huntsworth's is -0.3623. This would suggest that Huntsworth's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Huntsworth has bucked the trend.
Huntsworth plc, together with its subsidiaries, operates as a healthcare and communications company in the United Kingdom and rest of Europe, the United States, and internationally. The company operates through four divisions: Medical, Marketing, Immersive, and Communications. The Medical division provides scientific strategy and communications, publications planning and delivery, specialized medical writing, medical education, and payer and value communications services, as well as support services for internal medical teams. This division serves pharmaceutical and biotechnology clients. The Marketing division markets prescription drugs to consumers and healthcare professionals; and provides healthcare public relations agency and payer marketing services. This segment serves biotech and pharma, OTC, wellness, and lifestyle brands. The Immersive division creates and delivers live experiences, and scientific and interactive contents; creates and produces various films, including short and internal engagement films, documentaries, and action demonstrations; develops immersive experiences for employees training and explaining complex science; and designs strategic and creative programs to engage internal audiences. This division primarily serves healthcare industry. The Communications division provides public relations and affairs, and investor relations solutions; and communication consulting services primarily for cross-border financial transactions and multinationals to broaden their global footprint, as well as develops and manages campaigns, runs press offices, and steers brands and businesses through engagement with media, consumers, customer stakeholders, and internal audiences. The company was formerly known as Holmes & Marchant Group plc and changed its name to Huntsworth plc in July 1999. Huntsworth plc was incorporated in 1983 and is headquartered in London, the United Kingdom.
Find out the best pension drawdown for different sized pension pots and different investing aims. We’ve compared the different providers.
Find out more about the London Stock Exchange, what companies are listed on it and how to invest in the largest exchange in Europe.
Find out what we thought of the Wealthsimple pension, including details on fees, funds and the features in the three different tiers.
Find out more about the Nikkei 225, some companies that make it up and how you can invest in the Nikkei 225.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.